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Who should be referring to the Facial Pain Service?   
Abstract  
 
Aim : 
To determine who refers patients to a facial pain service, to assess the quality of the 
referral letters.   
 
Method  
The source of all referral letters to the service for 5 years were established. For one 
year  the information provided in 94 referrals was assessed.  
Using a predetermined checklist of essential information the referral letters were 
compared to these set criteria.  
 
Results: 
The service received > 1000 referrals annually and on average GDPs referred 303 
more patients per year than GMPs. 71% of all referrals were from primary care 
practitioners, the rest from specialists.   
Over 70% of GMP and 52% of GDP letters included a past medical history, with 
GMPs more likely to suggest a possible diagnosis and include previous secondary 
care referrals. The mean score for GMP referrals compared to the standard proforma 
(max 12) was 5.6 and for GDP referrals 5.0. A relevant drug history was included by 
75.6% GMP compared to 38.7% of GDPs. GMPs were more likely to include any 
relevant mental health history.  
 
Conclusions: 
The overall quality of referral letters is low.  If referrals were only accepted from 
GMPs, potentially improved management of patients would ensue.  
  
Introduction 
Chronic facial pain is a long-term condition that is often extremely complex, and 
frequently requires input from the secondary care sector. Patients will frequently 
access both their General Dental Practitioner (GDP) and General Medical 
Practitioner (GMP) in their attempts to find a cure. 1 It is therefore essential that all 
service providers communicate with each other effectively. However, it has been 
shown that this is often not the case, particularly due to the multidisciplinary nature of 
this condition. 2, 3  
 
The initial main form of communication is the referral letter, which therefore needs to 
be of good quality.  A medical history including past and present medications helps 
prevent polypharmacy and encourages safer prescribing, in addition to assisting the 
specialist in formulating a management plan without additional ‘time-wasting’ 
correspondence with the GDP or GMP.  Referral letters continue to be inadequate, 
and even contain inaccurate information. 4  One study found that only 58% of referral 
letters gave an accurate list of medications and drug doses used by their patients. 5 
Furthermore it has been shown that medical information provided by GDPs is of 
inferior quality compared to GMPs. 6 GDPs referring to orthodontics make no 
mention of a medical history in 80% of instances  7 and only 60% of letters 
requesting sedation for extractions contained sufficient medical history. 8 
 
Patients with chronic facial pain have considerable co-morbidities that require 
complex interventions. 9  GDPs refer patients with non-dental facial pain and so, their 
subsequent management will often be shared between the specialist centres and the 
GMP, as GDPs are very restricted in the medications they can prescribe. On the 
other hand, GMPs referring patients to a facial pain service will probably have been 
unable to eliminate a dental cause for the pain, and in some instances should have 
suggested patients first see their GDPs.    
 
This study aimed to determine who initially refers patients to a national facial pain 
service, assess the quality of referral letters with respect to the ability of hospital 
specialists to triage patients to appropriate pathways and initiate a shared treatment 
plan which includes prescribing. It also aimed to establish whether all referrals 
should come via the GMPs rather than GDPs, in view of their complexity using a 
standardized proforma.   
Methods 
The study took place in a London based secondary and tertiary referral centre 
specialising in the treatment of chronic, complex non-dental facial pain that does not 
include headaches or migraines.  
 
All referral letters to the facial pain service are triaged by a senior clinician who 
maintains a database recording the source of the referral. If the primary care letter 
includes correspondence from a secondary care provider or this is mentioned in the 
letter then a separate note is made that the primary care referral is essentially a 
secondary or tertiary care referral. Based on all the details in the referral letter, 
patients are then allocated to varying clinicians dependant on the skills required. If 
there is insufficient detail provided, referrals are sent back to the referrer for 
clarifications. If medical histories are missing, GMPs are contacted irrespective of 
whether they referred the patient.  
 
For the review of the source of referrals, all referral letters were considered from 
April 2007 to October 2012. The review of information provided by referrals was 
limited to 94 referrals from primary care sources over a one year period, 50 GDP and 
44 GMP letters.  Each clinician keeps a database of all patients allocated to them, 
which includes the diagnosis. The commonest condition that was referred was 
temporomandibular disorders (TMD).  
 
Outcome measures: A checklist of essential information required when referring a 
patient with chronic facial pain was developed based on standards set by several 
research publications, including Ryle 10 and Zakrzewska 11, and the referral proforma 
used by UCLH is available online (http://www.uclh.nhs.uk/OurServices/ServiceA-
Z/EDH/MAXMED/FPAIN/Pages/refer.aspx),. A gold standard was devised to which 
referral letters were compared. For the 12 items a score of 0 indicated not 
present/inadequate, 1was present/adequate so the maximum score was 12. These 
criteria and further details are shown in table 1.  
 Insert Table 1 here  
 
Relevant past medical histories mentioned within the referral letter were noted and 
compared to the corresponding medical histories taken by the medical team in the 
service.  Where there was no medical history it was classified as “No”, whereas 
where a relevant medical history was provided and was adequate, it was termed a 
“Yes” and where a medical history was present but not provided in the referral letter, 
it was classified as “Inadequate”. 14 items of the medical history were considered 
important.  
 
Power of the study  
 
Previous reviews of papers dealing with referral letters used 100 letters. 12, 13  In 
order to obtain an equal number of simple and complex cases for analysis, letters 
were taken in an approximately equal proportion across all three databases (patients 
seen by the consultant, specialist registrar and foundation dentist). In total 94 referral 
letters were obtained, 50 of which were GDP letters and 44 GMP referrals. The 
foundation dentists are not often allocated patients referred by GMPs. They saw 17 
of the patients referred by the GDP, and 11 from the GMP. The specialist registrar 
saw 17 patients each from the two referrers, and the consultant 16.  
Results 
Source of referrals  
Over the 5 year period, on average, over 1,000 referrals were made to the service 
annually. Of those, 15% to 29% (an average of 299 referrals) were rejected each 
year as they did not conform to the criteria for referral, did not require secondary 
care input, or provided inadequate information. Of the rejected referrals, the highest 
proportion came from the GDP, making up 84% of the total referrals not accepted by 
the service.   
 
Of those patients accepted, between 25-30% (average of 241 referrals) either Do 
Not Attend (DNA) or do not make an appointment when invited to do so. In the year 
2009 to 2010, referrals came from 80 Primary Care Trusts (at the time there were 95 
PCT), with one local PCT referring 90 patients, with other more local PCTs between 
30 to 60, and overall 31 PCTs referred more than 10 new patients in a year.   
 
More GDPs refer into the service than GMPs as shown in Figure 1, and this 
proportion is stable over the years. On average GDPs refer 303 more patients per 
year compared to GMPs. 
 
Figure 1 Number of GDP and GMP referrals received by the centre per year  
 
 
On average, 29% of accepted referrals are referred directly from specialists. 
However, on analyzing the referral letters from GDP and GMPs, it is evident that on 
average 44.3% of letters per year are actually already tertiary referrals as they either 
mention or provide letters from secondary care providers. This is an additional 
number of 175 referrals per year that are actually tertiary referrals.  
Adequacy of referral letters  
A total of 94 referral letters from the period of 2013 to 2014 was collected for 
analysis. Of these, 50 were GDP referrals and 44 from GMPs.  
 
The breakdown items of orofacial pain included in the referral letters are shown in 
Table 1. Characteristics of the pain mentioned by the practitioners are relatively 
equal. The most frequent category not included in GDP and GMP referral letters 
were social and family history, being present in only 12% and 22.7% of letters 
respectively. Over 70% of GMP letters and 52% of GDP letters included some past 
medical history. GMPs were much more likely to put forward a possible diagnosis 
and include information about secondary care referrals. 
 
The mean score for GMP referrals out of 12 was 5.6 (standard deviation 2.6, range 
1-12). Mean score for GDP referrals was 5.0 (standard deviation 2.2, range 1-9) 
 
UCLH website has a recommended proforma, and this was used by 10 GDP and 6 
GMPs, with average scores of 5.8 and 6 respectively.   
 
Table 2 shows the medical history completeness in the referral letters. There was no 
relevant medical history in 2 patients, and these have been adjusted for in the table. 
Overall GMPs letters were more complete.  
 
Insert table 2 here  
 
Table 3 details contents of referral letters from the GMP, and Table 4 shows GDP 
contents of referral letters.  
 
Insert table 3 and 4 here  
 
It was found that 41 patients referred from the GMP contained a relevant drug 
history. Of these, 75.6% of letters included this information but 24.4% did not. In 
comparison, only 38.7% of the 31 GDP referral letters included the relevant drug 
history, with 61.3% of the letters not giving it any mention at all. One referral quoted 
no medical history and yet the patient had multiple medical problems and was on 12 
prescribed medications. 
 
Out of the 94 referrals, mental health history was present in 39 patients but only 18 
letters gave any mention of this. The GMP was more likely (66.7%) than the GDP 
(28.6%) to mention a mental health history.  For example one GDP made no mention 
that the patient had bulimia and Asperger’s syndrome and had also been admitted 
for an overdose.  
Discussion  
Although GDPs were the most frequent referrers 44%  of patients had  already 
attended a secondary care service which suggests that many secondary care 
services either do not have the skills or do not have the resources to manage these 
potentially complex patients, which reflects the experience of a unit in the North of 
England 3. A review of referrals in 2011 for temporomandibular disorders (TMD) to 
this service which constitute 45% of referrals showed that 46% had seen both GMP 
and GDP, 20% had only consulted a GDP, and 14% only a GMP. However 42% had 
already been to see another specialist which included oral and maxillofacial 
surgeons, ENT surgeons, neurologists, physicians, and pain specialists in order of 
frequency. This could be due to greater patient anxiety as found in a study 
comparing headache patients managed in primary care and those by neurologists. 14  
 
This study looked at a total of 94 referral letters over a one year period, as has 
previously been done in other studies. 12; 13  Similar to De Angelis et al   6  finding 
GMPs provide more information. GMPs  are more likely to attempt to make a 
diagnosis, 73% GMPs compared to 54% GDPs, which nevertheless is higher than 
Navarro et al 15  reported about oral medicine referrals, where only 16% did so. 
Mental health problems are often not mentioned especially by GDPs and yet were 
present in 41% of the patients.  These are known to constitute significant co-
morbidity for orofacial pain patients. An orofacial pain clinic in Japan found half their 
patients (60) had mental health disorders. 16 
 
Although overall there was no significant improvement in the referral letter score with 
the proforma, there was no significant difference in the quality of referrals from 
GMPs and GDPs when it is used, but this could have been due to small sample size. 
Djemal et al 13 and Shaffie and Cheng  17 both found referrals from GDPs improved 
when using a proforma. But on the other hand Denith et al  8 although finding 
medical histories improved with use of proformas, found less general information 
was provided something noted in this study. Some practitioners include a cover letter 
providing some of this data.  A Cochrane review looking at interventions to improve 
referrals found structured proformas could help but local educational interventions 
were equally important. 18  Kripke 19 suggests that guidelines are also useful and that 
the education should be delivered by specialist consultants. This needs re-enforcing 
as fall off is noticed after 2 years. 20 
 
A detailed past medical history and possible diagnosis is indispensable in enabling 
appropriate triaging to occur, in addition to allowing specialists to manage the patient 
in a holistic manner along appropriate care-pathways. A good referral letter helps cut 
down on the time needed to collect data, and allows specialists more time on 
information giving and management decisions. Inadequacy of GDP referrals could in 
part be due to general perception amongst the public that GDPs do not need to know 
their patients’ medical history, and so some patients will not disclose information 
which may be of relevance. 21  
 
Medications cannot be prescribed without an adequate medical and drug history. 
Prescribers must check that lists provided by GMPs are accurate, as a study has 
shown that 37% of lists may be inaccurate and dosages were not accurate in 16% of 
referrals. 5 It is also very helpful if details of previous drugs used for the condition are 
provided, as it can be determined whether adequate doses have been used for a 
sufficient length of time and how well tolerated they were.  
 
Given that a number of GDP letters are deemed inadequate, ensuring that referrals 
only come from GMPs could improve the information available to the specialists. 
However GDPs are very effective at ruling out dental causes. Only 8% of referrals to 
the service are determined to have a primary dental cause. If GMPs refer they will be 
aware that a treatment plan will be provided and shared care may be needed.  
 
Conclusions 
Although GMPs send more appropriate referral letters than GDPs, and include 
relevant past medical history, our study shows that the overall quality of the referral 
letter needs to be improved. Currently the average GDP and GMP referral letter 
does not include sufficient details to enable accurate triaging. This is essential in 
allowing secondary care specialists to put forward a comprehensive treatment plan, 
and prescribe appropriate medication safely. Two key areas which were often 
missed that need to be included within the referral letter are drug history and mental 
health problems. It may be useful if all potential referrals are initially screened by 
GDPs for dental causes of pain, but are then referred to secondary centres by GMPs 
on proforms. This will help improve the adequacy of the referral, and also ensure that 
GMPs who will ultimately be responsible for managing these patients are aware of 
their condition. 
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Table 1 Details of pain complaint provided in 50 letters from GDPs and 44 from 
GMPs 
Referral information  GDP (n= 50) GMP (n= 44) 
Duration of pain  68.0% (34)  68.2% (30) 
Periodicity of pain  34.0% (17) 27.3% (12) 
Site of pain  88.0% (44) 79.5% (35) 
Characteristic of pain  20.0% (10) 20.5% (9) 
Severity of pain  28.0% (14) 31.8% (14) 
Exacerbating/alleviating factors of pain  42.0% (21) 47.7% (21) 
Associated factors  38.0% (19) 31.8% (14) 
Overall past medical history  52.0% (26) 70.5% (31) 
Treatment to date 60.0% (30) 56.8% (25) 
Secondary care 14.0% (7) 34.1% (15) 
Social/family history  12.0% (6) 22.7% (10) 
Diagnosis  54.0% (27) 72.7% (32) 
 
  
 Table 2 Medical History completeness for all referrals  
Completeness All referrals  (n= 
92) 
 
GMP referral (n= 
43) 
GDP referrals (n= 
49) 
Complete history  13.0% (12) 27.9% (12)  0% (0)  
One relevant 
finding missing  
19.6% (18) 25.6% (11) 16.3% (7) 
Two relevant 
finding missing 
22.8% (21) 18.6% (8) 26.5% (13) 
Three or more 
relevant finding 
missing 
45.7% (42) 30.2% (13) 59.2% (29) 
Average relevant 
findings missing* 
2.48 
 
 
1.88 3.00 
Average 
completeness** 
43.1% 61.1% 23.8% 
 
  
 Table 3 GMP referral letter completeness 
 
Medical history finding Total  
(n= 43) 
Not in referral  In referral 
 
Previous operative 
procedures or inpatient 
admission  
51.2% (22) 
 
54.5% (12) 45.5% (10) 
Drug history  95.3% (41) 24.4% (10) 75.6% (31) 
Allergies  30.2% (13) 46.2% (6) 53.8% (7) 
Cardiovascular history  14.0% (6) 16.7% (1) 83.3% (5) 
Blood pressure  30.2% (13) 46.2% (6) 53.8% (7) 
Respiratory history  20.9% (9) 22.2% (2) 77.8% (7) 
Endocrine history  11.6% (5) 20.0% (1) 80.0% (4) 
GI/liver disease history  41.9% (18) 44.4% (8) 55.6% (10) 
Renal history  2.3% (1) 100.0% (1) 0.0% (0) 
Rheumatology history  55.8% (24) 62.5% (15) 37.5% (9) 
Dermatology history  18.6% (8) 37.5% (3) 62.5% (5) 
Neurological history  39.5% (17) 47.1% (8) 52.9% (9) 
Psychiatric history 41.9% (18) 33.3% (6) 66.7% (12) 
Other  37.2% (16) 12.5% (2) 87.5% (14) 
 
  
  
Table 4 GDP referral letter completeness 
 
Medical history finding Total 
(n= 49) 
Not in referral  In referral 
 
Previous operative 
procedures or inpatient 
admission  
59.2% (29) 
 
89.7% (26) 10.3% (3) 
Drug history  63.3% (31) 61.3% (19) 38.7% (12) 
Allergies  24.5% (12) 75.0% (9) 25.0% (3) 
Cardiovascular history  12.2% (6) 83.3% (5) 16.7% (1) 
Blood pressure  10.2% (5) 40.0% (2) 60.0% (3) 
Respiratory history  18.4% (9) 88.9% (8) 11.1% (1)  
Endocrine history  10.2% (5) 60.0% (3) 40.0% (2) 
GI/liver disease history  32.7% (16) 81.3% (13) 18.7% (3) 
Renal history  81.6% (4) 75.0% (3) 25.0% (1) 
Rheumatology history  40.8% (20) 85.0% (17) 15.0% (3) 
Dermatology history  18.4% (9) 100.0% (9) 0.0% (0) 
Neurological history  20.4% (10) 80.0% (8) 20.0% (2) 
Psychiatric history 42.9% (21) 71.4% (15) 28.6% (6) 
Other  28.6% (14) 64.3% (9) 35.7% (5) 
 
